TITLE

Platelets in inflammatory bowel disease

AUTHOR(S)
Matsumoto, Takayuki
PUB. DATE
January 2006
SOURCE
Journal of Gastroenterology;Jan2006, Vol. 41 Issue 1, p91
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article discusses the increased accumulation response of platelets in patients with inflammatory bowel disease (IBD). The regulation of the platelet activation for IBD has the potential for a successful treatment of the disease. A study has found out that platelets play an important role in thrombosis as well as in immune responses that may cause and/or maintain persistent mucosal inflammation in IBD.
ACCESSION #
19870720

 

Related Articles

  • New serological markers in inflammatory bowel disease are associated with complicated disease behaviour. Ferrante, Marc; Henckaerts, Liesbet; Joossens, Marie; Pierik, Marie; Joossens, Sofie; Dotan, Nir; Norman, Gary L.; Altstock, Rom T.; van Steen, Kristel; Rutgeerts, Paul; van Assche, Gert; Vermeire, Séverine // Gut;Oct2007, Vol. 56 Issue 10, p1394 

    Background and aims: Several antibodies have been associated with Crohn's disease and are associated with distinct clinical phenotypes. The aim of this study was to determine whether a panel of new antibodies against bacterial peptides and glycans could help in differentiating inflammatory bowel...

  • Brachiocephalic vein thrombosis associated with Crohn's disease. Ribeiro, João M.; Rebocho, Luísa; Lucas, Margarida B.; Campos, Paula; Victorino, Rui M. M. // Journal of Gastroenterology;2003, Vol. 38 Issue 3, p268 

    An association between macrovascular thrombosis and idiopathic inflammatory bowel disease has been described, although very few well-documented cases have been published. We report on a 39-year-old woman who presented with right hemifacial and upper limb edema that was shown to be due to an...

  • Immunoregulatory actions of epithelial cell PPAR gamma at the colonic mucosa of mice with experimental inflammatory bowel disease.  // Inflammatory Bowel Disease Monitor;2010, Vol. 11 Issue 1, p31 

    No abstract available.

  • Tolerance and Inflammation at the Gut Mucosa. Faria, AnaMaria C.; Mucida, Daniel; McCafferty, Donna-Marie; Tsuji, Noriko M.; Verhasselt, Valerie // Clinical & Developmental Immunology;2012, p1 

    An introduction is presented in which the editor discusses various reports within the issue on topics including the pathogenesis of inflammatory bowel diseases (IBDs), gut immune responses, and food allergy development.

  • Connecting the dost from Toll-like receptors to innate immune cells and inflammatory bowel disease. Boone, David L.; Ma, Averil // Journal of Clinical Investigation;5/1/2003, Vol. 111 Issue 9, p1284 

    Addresses the approaches that may provide novel therapeutic targets for the treatment of inflammatory bowel diseases. Negative regulators of inflammation; Physiological importance of IL-10 receptor; First step in initiating immune responses.

  • Effect of Iron Therapy on Platelet Counts in Patients with Inflammatory Bowel Disease-Associated Anemia. Kulnigg-Dabsch, Stefanie; Evstatiev, Rayko; Dejaco, Clemens; Gasche, Christoph // PLoS ONE;Apr2012, Vol. 7 Issue 4, p1 

    Background and Aims: Secondary thrombocytosis is a clinical feature of unknown significance. In inflammatory bowel disease (IBD), thrombocytosis is considered a marker of active disease; however, iron deficiency itself may trigger platelet generation. In this study we tested the effect of iron...

  • Mean Platelet Volume: A Useful Marker of Inflammatory Bowel Disease Activity. Kapsoritakis, Andreas N.; Koukourakis, Michael I.; Sfiridaki, Aekaterini; Potamianos, Spiros P.; Kosmadaki, Maria G.; Koutroubakis, Ioannis E.; Kouroumalis, Elias A. // American Journal of Gastroenterology;Mar2001, Vol. 96 Issue 3, p776 

    OBJECTIVES: We investigated whether the mean platelet volume would be a useful marker in the evaluation of inflammatory bowel disease activity. METHODS: Complete blood count, C-reactive protein, erythrocyte sedimentation rate, serum thrombopoietin and erythropoietin, plasma β-thromboglobulin,...

  • Effect of Iron Therapy on Platelet Counts in Patients with Inflammatory Bowel Disease-Associated Anemia. Kulnigg-Dabsch, Stefanie; Evstatiev, Rayko; Dejaco, Clemens; Gasche, Christoph // PLoS ONE;Apr2012, Vol. 7 Issue 4, p1 

    Background and Aims: Secondary thrombocytosis is a clinical feature of unknown significance. In inflammatory bowel disease (IBD), thrombocytosis is considered a marker of active disease; however, iron deficiency itself may trigger platelet generation. In this study we tested the effect of iron...

  • Pre- and Posttherapy Assessment of Intestinal Soluble Mediators in IBD: Where We Stand and Future Perspectives. Scaldaferri, F.; Petito, V.; Lopetuso, L.; Bruno, G.; Gerardi, V.; Ianiro, G.; Sgambato, A.; Gasbarrini, A.; Cammarota, G. // Mediators of Inflammation;2013, Vol. 2013, p1 

    Inflammatory bowel disease (IBD) is a chronic inflammatory condition characterized by an abnormal immune response against food or bacterial antigens in genetically predisposed individuals. Several factors of innate and adaptive immune system take part in the inflammatory process, probably...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics